To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to manipulate a type of immune cell called a macrophage, causing it to protect the ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...

Researchers have developed a chemical probe to study a key component of the Mycobacterium tuberculosis envelope. Their ...

An immunoblotting technique determined that the probe interacts with a specific receptor — a protein known as TREM2 — on ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present two poster abstracts at the ...

Richard Staines spoke with Soren Bregenholt, the new CEO of Macrophage Pharma, about the company’s strategy encompassing both immune oncology and inflammatory diseases. In healthy tissues ...

Pheast Therapeutics has treated the first patient in a phase 1 trial of PHST001, a novel macrophage checkpoint inhibitor for advanced solid tumors.

In 2008, a group of published studies claimed that a treatment called Gc protein-derived macrophage-activating factor (GcMAF) had wiped out breast, colorectal, and prostate cancers. The studies ...

Inflammatory processes are the body’s defence against local damage and disease. Inflammation involves the influx into organs of immune cells (white blood cells) from the blood. These cells deal with ...

With a three-minute presentation on cancer research, Kirstin Rollins, a PhD student in the Department of Molecular, Cellular, ...